Ardent Health, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
8.78
+0.19 (2.21%)
At close: Mar 25, 2026, 4:00 PM EDT
8.78
0.00 (0.00%)
After-hours: Mar 25, 2026, 7:00 PM EDT
Ardent Health Stock Forecast
Stock Price Forecast
The 10 analysts that cover Ardent Health stock have a consensus rating of "Buy" and an average price target of $13.2, which forecasts a 50.34% increase in the stock price over the next year. The lowest target is $10 and the highest is $17.
Price Target: $13.2 (+50.34%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Ardent Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 6 | 4 | 4 | 4 | 4 | 4 |
| Hold | 2 | 3 | 3 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $14 → $13 | Buy | Maintains | $14 → $13 | +48.06% | Mar 10, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $16 → $15 | Buy | Maintains | $16 → $15 | +70.84% | Mar 6, 2026 |
| JP Morgan | JP Morgan | Hold Maintains $12 → $11 | Hold | Maintains | $12 → $11 | +25.28% | Jan 20, 2026 |
| UBS | UBS | Strong Buy Maintains $15 → $14 | Strong Buy | Maintains | $15 → $14 | +59.45% | Dec 18, 2025 |
| Mizuho | Mizuho | Buy Maintains $20 → $12 | Buy | Maintains | $20 → $12 | +36.67% | Dec 18, 2025 |
Financial Forecast
Revenue This Year
6.70B
from 6.32B
Increased by 5.89%
Revenue Next Year
7.00B
from 6.70B
Increased by 4.52%
EPS This Year
1.37
from 0.96
Increased by 42.76%
EPS Next Year
1.50
from 1.37
Increased by 9.13%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.0B | 7.4B | |
| Avg | 6.7B | 7.0B | |
| Low | 6.4B | 6.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.6% | 10.5% | |
| Avg | 5.9% | 4.5% | |
| Low | 1.1% | -2.1% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | 2.00 | 2.21 |
| Avg | 1.37 | 1.50 |
| Low | 1.07 | 1.14 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | 107.8% | 60.9% |
| Avg | 42.8% | 9.1% |
| Low | 11.3% | -17.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.